Market Overview

UPDATE: Citigroup Initiates Healthways at Sell; EPS Expectations Are Optimistic

Share:
Related HWAY
Healthways Up 100% In The Last Month, But UBS Says Sell
Healthways Upgraded By Barclays On Improved Operating Focus

Citigroup initiated coverage on Healthways (NASDAQ: HWAY) with a Sell rating and a $9 price target.

Citigroup noted, "Consensus expects Healthways to earn $0.72 per share in 2014, more than double what the company is expected to earn in 2013. The view is based on the assumption that Healthways can improve margins by over 200 basis points. We think contract losses, lower margins on new business, and less favorable rates on renewed contracts will pressure margins relative to the consensus view. Moreover, investment spend could accelerate ahead of healthcare reform, limiting upside."

Healthways closed at $10.81 on Monday.

Latest Ratings for HWAY

DateFirmActionFromTo
Aug 2016UBSDowngradesNeutralSell
Aug 2016BarclaysUpgradesUnderweightEqual-weight
Aug 2016JefferiesMaintainsHold

View More Analyst Ratings for HWAY
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (HWAY)

View Comments and Join the Discussion!